SE8801964D0 - New 5-(omega-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes - Google Patents

New 5-(omega-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes

Info

Publication number
SE8801964D0
SE8801964D0 SE8801964A SE8801964A SE8801964D0 SE 8801964 D0 SE8801964 D0 SE 8801964D0 SE 8801964 A SE8801964 A SE 8801964A SE 8801964 A SE8801964 A SE 8801964A SE 8801964 D0 SE8801964 D0 SE 8801964D0
Authority
SE
Sweden
Prior art keywords
tetrahydrothiophenes
tetrahydrofurans
new
methyles
ammonio
Prior art date
Application number
SE8801964A
Other languages
English (en)
Other versions
SE8801964L (sv
SE466449B (sv
Inventor
J-J Godfroid
F Heymans
P Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE8801964D0 publication Critical patent/SE8801964D0/sv
Publication of SE8801964L publication Critical patent/SE8801964L/sv
Publication of SE466449B publication Critical patent/SE466449B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8801964A 1987-05-29 1988-05-26 Nya 5-(w-ammoniumacyloximetylen)tetrahydrofuraner och -tetra-hydrotiofener, foerfarande foer framstaellning av dessa och en terapeutisk komposition SE466449B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc

Publications (3)

Publication Number Publication Date
SE8801964D0 true SE8801964D0 (sv) 1988-05-26
SE8801964L SE8801964L (sv) 1988-11-30
SE466449B SE466449B (sv) 1992-02-17

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8801964A SE466449B (sv) 1987-05-29 1988-05-26 Nya 5-(w-ammoniumacyloximetylen)tetrahydrofuraner och -tetra-hydrotiofener, foerfarande foer framstaellning av dessa och en terapeutisk komposition

Country Status (32)

Country Link
US (1) US5017588A (sv)
JP (1) JPH0631228B2 (sv)
KR (1) KR960005152B1 (sv)
AR (1) AR243885A1 (sv)
AT (1) AT395715B (sv)
AU (1) AU610789B2 (sv)
BE (1) BE1002146A3 (sv)
CA (1) CA1317959C (sv)
CH (1) CH674985A5 (sv)
DE (1) DE3818106A1 (sv)
DK (1) DK167532B1 (sv)
ES (1) ES2009924A6 (sv)
FI (1) FI89353C (sv)
FR (2) FR2615854B1 (sv)
GB (2) GB8712693D0 (sv)
GR (1) GR1000147B (sv)
HK (1) HK101790A (sv)
IE (1) IE61341B1 (sv)
IN (1) IN168799B (sv)
IT (1) IT1219698B (sv)
LU (1) LU87229A1 (sv)
MA (1) MA21289A1 (sv)
MY (1) MY103289A (sv)
NL (1) NL192203C (sv)
NO (1) NO170086C (sv)
NZ (1) NZ224775A (sv)
OA (1) OA08878A (sv)
PT (1) PT87585B (sv)
SE (1) SE466449B (sv)
SG (1) SG93790G (sv)
TN (1) TNSN88049A1 (sv)
ZA (1) ZA883731B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
NL8801315A (nl) 1988-12-16
ATA140788A (de) 1992-07-15
FR2615735B1 (fr) 1991-01-11
LU87229A1 (fr) 1988-12-13
DK291088D0 (da) 1988-05-27
JPS649988A (en) 1989-01-13
NO882335D0 (no) 1988-05-27
FI882475A0 (fi) 1988-05-26
GB2205100A (en) 1988-11-30
IT8820773A0 (it) 1988-05-27
BE1002146A3 (fr) 1990-07-31
TNSN88049A1 (fr) 1990-07-10
US5017588A (en) 1991-05-21
KR880013928A (ko) 1988-12-22
OA08878A (fr) 1989-10-31
IN168799B (sv) 1991-06-08
KR960005152B1 (ko) 1996-04-22
ZA883731B (en) 1989-02-22
NO170086B (no) 1992-06-01
HK101790A (en) 1990-12-14
NO882335L (no) 1988-11-30
FI882475A (fi) 1988-11-30
GR1000147B (el) 1991-09-27
AR243885A1 (es) 1993-09-30
GR880100342A (en) 1989-02-23
IE61341B1 (en) 1994-11-02
MY103289A (en) 1993-05-29
MA21289A1 (fr) 1988-12-31
IT1219698B (it) 1990-05-24
NO170086C (no) 1992-09-09
CA1317959C (en) 1993-05-18
SG93790G (en) 1991-01-18
CH674985A5 (sv) 1990-08-15
AT395715B (de) 1993-02-25
NZ224775A (en) 1990-01-29
FR2615854A1 (fr) 1988-12-02
FI89353C (sv) 1993-09-27
GB8712693D0 (en) 1987-07-01
FR2615854B1 (fr) 1990-12-28
FR2615735A1 (fr) 1988-12-02
AU1672288A (en) 1988-12-01
PT87585A (pt) 1989-05-31
NL192203B (nl) 1996-11-01
DE3818106C2 (sv) 1993-07-01
AU610789B2 (en) 1991-05-23
IE881599L (en) 1988-11-29
DK291088A (da) 1988-11-30
GB2205100B (en) 1990-08-15
GB8812488D0 (en) 1988-06-29
DK167532B1 (da) 1993-11-15
SE8801964L (sv) 1988-11-30
FI89353B (fi) 1993-06-15
PT87585B (pt) 1992-09-30
SE466449B (sv) 1992-02-17
JPH0631228B2 (ja) 1994-04-27
ES2009924A6 (es) 1989-10-16
DE3818106A1 (de) 1988-12-15
NL192203C (nl) 1997-03-04

Similar Documents

Publication Publication Date Title
FI98460B (sv) Förfarande för framställning av ett terapeutiskt användbart 4H-1-bensopyran-4-onderivat eller dess salt samt en i förfarandet användbar mellanprodukt
EA199900242A1 (ru) Аралкил- и аралкилиден-гетероциклические лактамы и имиды
AU6129890A (en) Novel compounds
HUT56370A (en) Process for producing tricyclic carbapenem derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
ES2036926A1 (es) "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
FI101376B1 (sv) Förfarande för framställning av 3-bensylamino-2-fenylpiperidinderivat
HUP9903459A2 (hu) Oxa- és tiabiciklo[3.1.0]hexán-karbonsavak, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
JPS5665869A (en) Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug
SE8801964D0 (sv) New 5-(omega-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes
CA2030732A1 (fr) Nouveaux derives du thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
SE8801945L (sv) Nya 5-metoxi- aklylammonium- tetrahydrofuraner och -tetrahydrotiofener
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
FR2380272A1 (fr) Derives de la coumarine et d'indane-diode, utilisables comme medicament
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
SE8903313D0 (sv) New 2-methoxycarbonyl substituted n,n'-di(trimethoxybenzol) piperazines, process for preparing the same and therapeutical compounds compounds containing
ES2059572T3 (es) Derivado del antibiotico a 42867.
SE8802162L (sv) Nya aminoacylater av glycerolacetal
SE7907656L (sv) 3,4-dihydroxikanelaldehydderivat
ES469922A1 (es) Un procedimiento para la preparacion de un derivado del 1,1-dioxido del acido penicilanico
AU4930797A (en) New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them
ES8105734A1 (es) Un procedimiento para la preparacion de agentes antibacterianos beta-lactanicos.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8801964-1

Format of ref document f/p: F

NUG Patent has lapsed